EUVIMEDEUVIMED entdecken
Crossref

Dermal and Transdermal Macromolecule Delivery Using Enhancer Molecules and Colloidal Carrier Systems – Part 2: Percutaneous Administration of Heparin

Jamal Alyoussef Alkrad, Yousif Ali Almalki, Eman Zmaily Dahmash, Loay Khaled Hassouneh, Reinhard H H Neubert

Skin Pharmacology and Physiology · 2023 · 36 (1) · 16-26

DOI: 10.1159/000528189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Pharmacology and Physiology, online erschienen am 01.12.2022. Verfasst von Jamal Alyoussef Alkrad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Isra University, Amman, Jordan. Hauptthemen laut MEDLINE: Heparin, Skin. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Heparin is a commonly used anti-coagulant administered either by intravenous or subcutaneous injection for a systemic effect or topically for the treatment of peripheral vascular disorders.

Objective

This study aimed to formulate heparin in non-ionic colloidal carrier systems (CCSs) having enhanced percutaneous absorption for systemic and topical administration.

Methods

Five CCSs were developed and characterized for their rheological properties, droplet size, and drug loading. The percutaneous absorption of heparin was evaluated in vitro using Franz diffusion cells with rats’ skin and with the aid of a developed high-pressure chromatography method. Furthermore, the efficacy of two developed heparin CCSs was tested percutaneously in rats by measuring the response against the time in comparison to subcutaneous administration.

Results

The rheograms and droplet size measurements showed that the developed drug delivery systems have Newtonian properties with a droplet size between 109 and 460 nm. As much as 500 mg of heparin could be loaded in around 5 mL of CCS. Furthermore, using Franz diffusion cells, a diffusion rate of 19.216 ± 2.01 USP U/cm2.h could be achieved for heparin-loaded CCSs. Moreover, the estimated percutaneous in vivo relative bioavailability in comparison to subcutaneous administration could reflect that at least more than 50% of the drug passed through the skin.

Conclusion

The developed novel non-toxic CCSs containing heparin can be good candidates for percutaneous administration as alternative delivery systems for subcutaneous and intravenous invasive administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeparinSkinRatsAnimalsAdministration, CutaneousSkin AbsorptionDrug Delivery SystemsPharmaceutical Preparations

Stichwörter der Autor:innen

BioavailabilityColloidal carrier systemsHeparinPercutaneous absorptionPermeation

Substanzen

HeparinPharmaceutical Preparations

Autor:innen und Institutionen

  • Faculty of Pharmacy, Isra University, Amman, Jordan.
  • Department of Chemical and Pharmaceutical Sciences, School of Life Sciences, Pharmacy and Chemistry, Kingston University, London, UK.
  • Institute of Applied Dermatopharmacy, Martin Luther University Halle-, Wittenberg, Germany.

Zitieren

APA

Alyoussef Alkrad, J., Almalki, Y. A., Dahmash, E. Z., Hassouneh, L. K., & Neubert, R. H. H. (2023). Dermal and Transdermal Macromolecule Delivery Using Enhancer Molecules and Colloidal Carrier Systems – Part 2: Percutaneous Administration of Heparin. Skin Pharmacology and Physiology, 36(1), 16-26. https://doi.org/10.1159/000528189

Vancouver

Alyoussef Alkrad J, Almalki YA, Dahmash EZ, Hassouneh LK, Neubert RHH. Dermal and Transdermal Macromolecule Delivery Using Enhancer Molecules and Colloidal Carrier Systems – Part 2: Percutaneous Administration of Heparin. Skin Pharmacology and Physiology. 2023;36(1):16-26. doi:10.1159/000528189

BibTeX
@article{AlyoussefAlkrad2023,
  author = {Alyoussef Alkrad, Jamal and Almalki, Yousif Ali and Dahmash, Eman Zmaily and Hassouneh, Loay Khaled and Neubert, Reinhard H H},
  title = {Dermal and Transdermal Macromolecule Delivery Using Enhancer Molecules and Colloidal Carrier Systems – Part 2: Percutaneous Administration of Heparin},
  journal = {Skin Pharmacology and Physiology},
  year = {2023},
  volume = {36},
  number = {1},
  pages = {16--26},
  doi = {10.1159/000528189}
}
Kostenlos starten →